RG

Rameshchandra Giridharlal Modi

Active Director Director DIN 07037086
DIN 07037086 First appointment Jan 2015 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2015
Shareholding value β€’β€’β€’β€’ Premium profile

About Rameshchandra Giridharlal Modi

Data last updated:

Rameshchandra Giridharlal Modi is a Director at Amizyme Life Sciences Private Limited (since 2015). The company operates in Chemicals.

DIN 07037086
Primary Designation Director
Industry Chemicals
First Appointment 06 Jan 2015
Oldest Company Age 11 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director06 Jan 20152015Active

Board colleagues of Rameshchandra Giridharlal Modi

NameDINCompanyDesignation
Hiren Rameshbhai Modi07037092Amizyme Life Sciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Amizyme Life Sciences Private Limited
Premium access

Shareholding and investment profile for Rameshchandra Giridharlal Modi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rameshchandra Giridharlal Modi

Rameshchandra Giridharlal Modi currently holds 1 directorship: Amizyme Life Sciences Private Limited (Director, since 06 Jan 2015).

Rameshchandra Giridharlal Modi was first appointed on 06 Jan 2015 as Director at Amizyme Life Sciences Private Limited.

The current boards of Rameshchandra Giridharlal Modi's companies include Hiren Rameshbhai Modi (Amizyme Life Sciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available